Related references
Note: Only part of the references are listed.Metformin and heart failure-related outcomes in patients with or without diabetes: a systematic review of randomized controlled trials
Phiwayinkosi Dludla et al.
HEART FAILURE REVIEWS (2021)
The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 x 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)
Henrik Wiggers et al.
AMERICAN HEART JOURNAL (2021)
Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomes
Brendon L. Neuen et al.
DIABETES OBESITY & METABOLISM (2021)
Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis
Chia Siang Kow et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?
Teresa Salvatore et al.
BIOMEDICINES (2021)
Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes
Yoichi Sunagawa et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2021)
Metformin: A Novel Weapon Against Inflammation
Bo Bai et al.
FRONTIERS IN PHARMACOLOGY (2021)
The Association Between Metformin Treatment and Outcomes in Type 2 Diabetes Mellitus Patients With Heart Failure With Preserved Ejection Fraction: A Retrospective Study
Jianfang Wang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Cardiovascular events and mortality among type 2 diabetes mellitus patients newly prescribed first-line blood glucose-lowering drugs monotherapies: A population-based cohort study in the Catalan electronic medical record database, SIDIAP, 2010-2015
Raquel Herrera Comoglio et al.
PRIMARY CARE DIABETES (2021)
Hospitalization for Heart Failure Among Patients With Diabetes Mellitus and Reduced Kidney Function Treated With Metformin Versus Sulfonylureas: A Retrospective Cohort Study
Tadarro L. Richardson et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease
Ferdinando Carlo Sasso et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: An observational study using data from routine care
Michael Fralick et al.
DIABETES OBESITY & METABOLISM (2021)
GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials
Apostolos Tsapas et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2021)
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence
Alfredo Caturano et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2021)
Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model
Denisa Miklankova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Metformin protects against insulin resistance induced by high uric acid in cardiomyocytes via AMPK signalling pathways in vitro and in vivo
Zhenyu Jiao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study
Siyao He et al.
JOURNAL OF DIABETES RESEARCH (2021)
Inflammatory Cytokines, Immune Cells, and Organ Interactions in Heart Failure
Huihui Li et al.
FRONTIERS IN PHYSIOLOGY (2021)
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
Teresa Salvatore et al.
FRONTIERS IN MEDICINE (2021)
Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial
Ricardo Ladeiras-Lopes et al.
ENDOCRINE (2021)
Astragaloside IV promotes the eNOS/NO/cGMP pathway and improves left ventricular diastolic function in rats with metabolic syndrome
Xin Lin et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
Metabolic Remodeling Promotes Cardiac Hypertrophy by Directing Glucose to Aspartate Biosynthesis
Julia Ritterhoff et al.
CIRCULATION RESEARCH (2020)
Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension
Jun Gu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes
Rosa Lombardi et al.
LIVER INTERNATIONAL (2020)
Does Metformin Interfere With the Cardiovascular Benefits of SGLT2 Inhibitors? Questions About Its Role as the Cornerstone of Diabetes Treatment
Milton Packer
AMERICAN JOURNAL OF MEDICINE (2020)
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Kerstin N. Timm et al.
CARDIOVASCULAR DRUGS AND THERAPY (2020)
Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy?
Silvio E. Inzucchi et al.
DIABETES OBESITY & METABOLISM (2020)
Metformin: An old drug against old age and associated morbidities
Teresa Salvatore et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
A randomised, double-blind, placebo-controlled trial of metformin on myocardial efficiency in insulin-resistant chronic heart failure patients without diabetes
Anders Hostrup Larsen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Intracanal Metformin Promotes Healing of Apical Periodontitis via Suppressing Inducible Nitric Oxide Synthase Expression and Monocyte Recruitment
Han-Wei Wang et al.
JOURNAL OF ENDODONTICS (2020)
Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
Pan Luo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Single-Cell Reconstruction of Progression Trajectory Reveals Intervention Principles in Pathological Cardiac Hypertrophy
Zongna Ren et al.
CIRCULATION (2020)
Longevity genes, cardiac ageing, and the pathogenesis of cardiomyopathy: implications for understanding the effects of current and future treatments for heart failure
Milton Packer
EUROPEAN HEART JOURNAL (2020)
Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map
Jianhong Zhu et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability
Biao Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages
Qin Fei et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients
Raffaele Marfella et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
The impact of metformin and aspirin on T -cell mediated inflammation: A systematic review of in vitro and in vivo findings
Tawanda Maurice Nyambuya et al.
LIFE SCIENCES (2020)
Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis
Amera Halabi et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF The CHAMP-HF Registry
Muthiah Vaduganathan et al.
JACC-HEART FAILURE (2020)
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
Xu Cheng et al.
CELL METABOLISM (2020)
Metformin protects high glucose-cultured cardiomyocytes from oxidative stress by promoting NDUFA13 expression and mitochondrial biogenesis via the AMPK signaling pathway
Xiang-Dong Liu et al.
MOLECULAR MEDICINE REPORTS (2020)
Metformin: A Potential Therapeutic Tool for Rheumatologists
Teresa Salvatore et al.
PHARMACEUTICALS (2020)
T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword
Karin H. Simons et al.
NATURE REVIEWS CARDIOLOGY (2019)
Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management
Fei Luo et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Mechanisms of action of metformin with special reference to cardiovascular protection
Alexey V. Zilov et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial
Mohapradeep Mohan et al.
EUROPEAN HEART JOURNAL (2019)
Cardiac Calcitropes, Myotropes, and Mitotropes JACC Review Topic of the Week
Mitchell A. Psotka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study
B. Zareini et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis
Yechen Han et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Metformin monotherapy significantly decreases epicardial adirose tissue thickness in newly diagnosed type 2 diabetes patients
Murat Ziyrek et al.
REVISTA PORTUGUESA DE CARDIOLOGIA (2019)
Class effects of SGLT2 inhibitors on cardiorenal outcomes
Aaron Y. Kluger et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction
Milton Packer
JOURNAL OF CARDIAC FAILURE (2019)
Metformin lactic acidosis: Should we still be afraid?
Teresa Salvatore et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis
Chin-Hsiao Tseng
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Soren L. Kristensen et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
AMPK: a therapeutic target of heart failure-not only metabolism regulation
Xuan Li et al.
BIOSCIENCE REPORTS (2019)
Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance
Rebecca E. Slater et al.
JOURNAL OF GENERAL PHYSIOLOGY (2019)
Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy
Fan Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Cardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction
Leon Varjabedian et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2018)
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial
Scott D. Solomon et al.
CIRCULATION-HEART FAILURE (2018)
Acute vs cumulative benefits of metformin use in patients with type 2 diabetes and heart failure
Daniala L. Weir et al.
DIABETES OBESITY & METABOLISM (2018)
Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling
Yapeng Li et al.
EXPERIMENTAL CELL RESEARCH (2018)
Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT
Simon J. Griffin et al.
HEALTH TECHNOLOGY ASSESSMENT (2018)
Mechanisms of physiological and pathological cardiac hypertrophy
Michinari Nakamura et al.
NATURE REVIEWS CARDIOLOGY (2018)
Metabolic remodelling in heart failure
Edoardo Bertero et al.
NATURE REVIEWS CARDIOLOGY (2018)
miRNA Regulation of the Hyperproliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes
Daniele Torella et al.
DIABETES (2018)
Metabolic Effects of Metformin in the Failing Heart
Aleksandra Dziubak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
Roger W. Hunter et al.
NATURE MEDICINE (2018)
Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes
Ferdinando Carlo Sasso et al.
JOURNAL OF DIABETES RESEARCH (2018)
Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition
Elisa Lozano et al.
JOURNAL OF PERSONALIZED MEDICINE (2018)
In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry
Giovanni Targher et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention
Sebastian Brings et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Metformin and risk of long-term mortality following an admission for acute heart failure
Lorenzo Facila et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2017)
Effects of metformin on blood pressure in nondiabetic patients: ameta-analysis of randomized controlled trials
Long Zhou et al.
JOURNAL OF HYPERTENSION (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Metformin attenuates ER stress-induced mitochondrial dysfunction
Qun Chen et al.
TRANSLATIONAL RESEARCH (2017)
Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study
Christianne L. Roumie et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
John R. Petrie et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage
Mario Masarone et al.
PLOS ONE (2017)
Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT
Minke H. T. Hartman et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy
Xiaoqiang Tang et al.
CIRCULATION (2017)
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
Simon J. Griffin et al.
DIABETOLOGIA (2017)
Metformin, beyond an insulin sensitizer, targeting heart and pancreatic β cells
Xin Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Seasonal variations of hyponatremia in the emergency department: Age-related changes
Mauro Giordano et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2017)
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
Floriana Morgillo et al.
ESMO OPEN (2017)
Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism
Dan Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction)
Soren L. Kristensen et al.
CIRCULATION (2017)
Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease A Systematic Review
Matthew J. Crowley et al.
ANNALS OF INTERNAL MEDICINE (2017)
The role of mitochondria in metabolism and cell death
Helin Vakifahmetoglu-Norberg et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice
Vinodkumar B. Pillai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Fuel availability and fate in cardiac metabolism: A tale of two substrates
Florencia Pascual et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
Yen-Chun Lai et al.
CIRCULATION (2016)
Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status
Amy R. Cameron et al.
CIRCULATION RESEARCH (2016)
Assessing Cardiac Metabolism A Scientific Statement From the American Heart Association
Heinrich Taegtmeyer et al.
CIRCULATION RESEARCH (2016)
Impact of Improved Glycemic Control on Cardiac Function in Type 2 Diabetes Mellitus
Melissa Leung et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2016)
Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial
Soren L. Kristensen et al.
CIRCULATION-HEART FAILURE (2016)
Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naive Type 2 Diabetes
Julio Rosenstock et al.
DIABETES CARE (2016)
= METFORMIN:NONGLYCEMIC EFFECTS AND POTENTIAL NOVEL INDICATIONS
Abeer Anabtawi et al.
ENDOCRINE PRACTICE (2016)
Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes A Meta-analysis
Suetonia C. Palmer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction
Lawien Al Ali et al.
PLOS ONE (2016)
The emerging role of Toll-like receptor 4 in myocardial inflammation
Y. Yang et al.
CELL DEATH & DISEASE (2016)
Metformin Protects H9C2 Cardiomyocytes from High-Glucose and Hypoxia/Reoxygenation Injury via Inhibition of Reactive Oxygen Species Generation and Inflammatory Responses: Role of AMPK and JNK
Mingyan Hu et al.
JOURNAL OF DIABETES RESEARCH (2016)
Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade
Fenqing Shang et al.
PLOS ONE (2016)
AMPK activators: mechanisms of action and physiological activities
Joungmok Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy
Lifang Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients
Colman Siu Cheung Fung et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry
Matthew A. Cavender et al.
CIRCULATION (2015)
Is AMPK the savior of the failing heart?
Ty T. Kim et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
Yoshifumi Saisho
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2015)
Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction
Hamid Soraya et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Metformin Protects Against Systolic Overload-Induced Heart Failure Independent of AMP-Activated Protein Kinase a2
Xin Xu et al.
HYPERTENSION (2014)
Effect of Metformin on Left Ventricular Function After Acute Myocardial Infarction in Patients Without Diabetes The GIPS-III Randomized Clinical Trial
Chris P. H. Lexis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Crosstalk between AMPK activation and angiotensin II- induced hypertrophy in cardiomyocytes: the role of mitochondria
Jessica Soto Hernandez et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1
Gauthier Noppe et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Metformin mitigates apoptosis in ischemic myocardium
Nassrene Y. Elmadhun et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Cardiac Metabolism in Heart Failure Implications Beyond ATP Production
Torsten Doenst et al.
CIRCULATION RESEARCH (2013)
Comparative Safety and Effectiveness of Metformin in Patients With Diabetes Mellitus and Heart Failure Systematic Review of Observational Studies Involving 34 000 Patients
Dean T. Eurich et al.
CIRCULATION-HEART FAILURE (2013)
Metformin revisited: A critical review of the benefit-risk balance in at-risk patients with type 2 diabetes
A. J. Scheen et al.
DIABETES & METABOLISM (2013)
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial
Satyam Sarma et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Metformin in lung cancer: rationale for a combination therapy
Floriana Morgillo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community
Sotero P. Romero et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Peroxisome Proliferator-activated Receptor γ Coactivator 1 (PGC-1)- and Estrogen-related Receptor (ERR)-induced Regulator in Muscle 1 (PERM1) Is a Tissue-specific Regulator of Oxidative Capacity in Skeletal Muscle Cells
Yoshitake Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Metformin Inhibits Angiotensin II-Induced Differentiation of Cardiac Fibroblasts into Myofibroblasts
Jian Bai et al.
PLOS ONE (2013)
Glucose Regulation of Load-Induced mTOR Signaling and ER Stress in Mammalian Heart
Shiraj Sen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Lipid Metabolism and Toxicity in the Heart
Ira J. Goldberg et al.
CELL METABOLISM (2012)
Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model
Antonio Cittadini et al.
DIABETES (2012)
The effect of metformin on insulin resistance and exercise parameters in patients with heart failure
Aaron K. F. Wong et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Short-term treatment with metformin suppresses toll like receptors (TLRs) activity in isoproterenol-induced myocardial infarction in rat: Are AMPK and TLRs connected?
Hamid Soraya et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Tight Glycemic Control May Increase Regenerative Potential of Myocardium during Acute Infarction
Raffaele Marfella et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials
Remy Boussageon et al.
PLOS MEDICINE (2012)
Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure
Meimei Yin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Oxidative stress and heart failure
Hiroyuki Tsutsui et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
Yu Li et al.
CELL METABOLISM (2011)
Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats
Cheng-Xi Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
Metformin improves cardiac function in rats via activation of AMP-activated protein kinase
Xiao-Fang Wang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
Effect of metformin therapy on cardiac function and survival in a volume-overload model of heart failure in rats
Jan Benes et al.
CLINICAL SCIENCE (2011)
Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice
Zhonglin Xie et al.
DIABETES (2011)
Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial
Robert J. Anderson et al.
DIABETES CARE (2011)
Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials
C. Lamanna et al.
DIABETES OBESITY & METABOLISM (2011)
Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study
Carlo B. Giorda et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2011)
Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
Jiangyong Ouyang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Effect of Metformin on Mortality in Patients With Heart Failure and Type 2 Diabetes Mellitus
Josie M. M. Evans et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Metformin Use and Mortality Among Patients With Diabetes and Atherothrombosis
Ronan Roussel et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Metformin attenuates cardiac fibrosis by inhibiting the TGFβ1-Smad3 signalling pathway
Han Xiao et al.
CARDIOVASCULAR RESEARCH (2010)
AMP-activated protein kinase and its downstream transcriptional pathways
Carles Canto et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Treatment of Type 2 Diabetes and Outcomes in Patients With Heart Failure: A Nested Case-Control Study From the UK General Practice Research Database
Michael R. MacDonald et al.
DIABETES CARE (2010)
Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study
C. Andersson et al.
DIABETOLOGIA (2010)
Metformin is associated with improved left ventricular diastolic function measured by tissue Doppler imaging in patients with diabetes
Charlotte Andersson et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Metformin Therapy and Outcomes in Patients With Advanced Systolic Heart Failure and Diabetes
Digish D. Shah et al.
JOURNAL OF CARDIAC FAILURE (2010)
ERKs and JNKs Mediate Hydrogen Peroxide-Induced Egr-1 Expression and Nuclear Accumulation in H9c2 Cells
I. -K. S. Aggeli et al.
PHYSIOLOGICAL RESEARCH (2010)
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
Kevin M. Pantalone et al.
ACTA DIABETOLOGICA (2009)
Metformin Prevents Progression of Heart Failure in Dogs Role of AMP-Activated Protein Kinase
Hideyuki Sasaki et al.
CIRCULATION (2009)
Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure
Susheel Gundewar et al.
CIRCULATION RESEARCH (2009)
AMPKα2 counteracts the development of cardiac hypertrophy induced by isoproterenol
Elharn Zarrinpashneh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality? A meta-analysis of observational studies
Ajay D. Rao et al.
DIABETES CARE (2008)
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure
Michael R. MacDonald et al.
EUROPEAN HEART JOURNAL (2008)
The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy
Finlay A. McAlister et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: A report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
Barry H. Greenberg et al.
AMERICAN HEART JOURNAL (2007)
Apoptosis in patients with dilated cardiornyopathy and diabetes: A feature of diabetic cardiomyopathy?
F. Kuethe et al.
HORMONE AND METABOLIC RESEARCH (2007)
Mechanisms of disease - The failing heart - An engine out of fuel
Stefan Neubauer
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy - A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
D. M. Nathan et al.
DIABETOLOGIA (2006)
AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B
L Bertrand et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Metformin inhibits proinflammatory responses and nuclear factor-κB in human vascular wall cells
K Isoda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase
BJ Davis et al.
DIABETES (2006)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Improved clinical outcomes associated with metformin in patients with diabetes and heart failure
DT Eurich et al.
DIABETES CARE (2005)
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure
W Doehner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Cardiomyocyte stiffness in Diastolic heart failure
A Borbély et al.
CIRCULATION (2005)
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure - An observational study
FA Masoudi et al.
CIRCULATION (2005)
The incidence of congestive heart failure associated with antidiabetic therapies
GA Nichols et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2005)
Determinants of subclinical diabetic heart disease
ZY Fang et al.
DIABETOLOGIA (2005)
Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure
I Gustafsson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Heart failure prevalence, incidence, and mortality in the elderly with diabetes
AG Bertoni et al.
DIABETES CARE (2004)
Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte
AYM Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus:: a systematic review
MG Wulffelé et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Modulation of NOS activity in age-related cardiac dysfunction
B Yang et al.
LIFE SCIENCES (2004)
Mechanisms for increased glycolysis in the hypertrophied rat heart
L Nascimben et al.
HYPERTENSION (2004)
The AMP-activated protein kinase pathway - new players upstream and downstream
DG Hardie
JOURNAL OF CELL SCIENCE (2004)
Excess mortality related to diabetes mellitus in elderly medicare beneficiaries
AG Bertoni et al.
ANNALS OF EPIDEMIOLOGY (2004)
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus - Systematic review and meta-analysis
SR Salpeter et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis
A Woods et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.
DR Bolster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Intracerebroventricular metformin attenuates salt-induced hypertension in spontaneously hypertensive rats
JS Petersen et al.
AMERICAN JOURNAL OF HYPERTENSION (2001)
Congestive heart failure in type 2 diabetes - Prevalence, incidence, and risk factors
GA Nichols et al.
DIABETES CARE (2001)
Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy:: evidence for the central role of energy compromise in disease pathogenesis
E Blair et al.
HUMAN MOLECULAR GENETICS (2001)
The effects of β1-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction -: A double-blind, placebo-controlled, positron-emission tomography study
RSB Beanlands et al.
CIRCULATION (2000)
Share Paper
